Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria
- PMID: 17504445
- PMCID: PMC2517299
- DOI: 10.1111/j.1365-2613.2007.00530.x
Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria
Abstract
Chronic active colitis (including inflammatory bowel disease - IBD) is maintained by a variety of pro-inflammatory mediators. Certain intestinal bacterial strains may induce colitis, whereas some strains (e.g. Lactobacillus spp.) show a protective effect in colitis owing to their anti-inflammatory activity. In this study, we have examined the production of selected inflammatory cytokines, reactive oxygen species (ROS), nitric oxide (NO) and the expression of haeme oxygenase-1 (HO-1) by murine peritoneal macrophages stimulated in vitro by the intestinal bacterial strains, isolated from mice with colitis. Lactobacillus strains (Lactobacillus reuteri, L. johnsonii, L. animalis/murinus) and two potentially pathogenic bacteria (Escherichia coli and Enterococcus faecalis) induced the production of substantial amounts of cytokines with a strain specific profile. Despite some interstrain differences, all lactobacilli induced production of anti-inflammatory cytokines (IL-10(high), IL-6(low), IL-12p70(low)). Conversely, E. faecalis and E. coli induced the production of proinflammatory cytokines (TNF-alpha, IL-12p70), the cytokines essential for chronic IBD. Macrophages released comparably substantial amounts of ROS in response to all Lactobacillus strains tested, while E. coli and E. faecalis ability to induce generation of ROS was negligible. In contrast to ROS, the production of NO/NO(2) (-) by macrophages activated with all bacterial strains tested was similar. Moreover, for the first time, it has been shown that intestinal bacteria differed in their ability to induce expression of HO-1, a stress-inducible enzyme with antioxidant and anti-inflammatory properties. The beneficial immunoregulatory properties of candidate probiotic bacteria for the treatment of IBD are discussed.
Figures




Similar articles
-
Lactic acid bacteria inhibit proinflammatory cytokine expression and bacterial glycosaminoglycan degradation activity in dextran sulfate sodium-induced colitic mice.Int Immunopharmacol. 2008 Apr;8(4):574-80. doi: 10.1016/j.intimp.2008.01.009. Epub 2008 Feb 5. Int Immunopharmacol. 2008. PMID: 18328449
-
Genotypic and phenotypic studies of murine intestinal lactobacilli: species differences in mice with and without colitis.Appl Environ Microbiol. 2004 Jan;70(1):558-68. doi: 10.1128/AEM.70.1.558-568.2004. Appl Environ Microbiol. 2004. PMID: 14711688 Free PMC article.
-
Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice.Infect Immun. 2005 Feb;73(2):912-20. doi: 10.1128/IAI.73.2.912-920.2005. Infect Immun. 2005. PMID: 15664933 Free PMC article.
-
Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance.J Endotoxin Res. 2000;6(3):205-14. J Endotoxin Res. 2000. PMID: 11052175 Review.
-
The regulation of immune cells by Lactobacilli: a potential therapeutic target for anti-atherosclerosis therapy.Oncotarget. 2017 Jun 2;8(35):59915-59928. doi: 10.18632/oncotarget.18346. eCollection 2017 Aug 29. Oncotarget. 2017. PMID: 28938693 Free PMC article. Review.
Cited by
-
Lactobacillus murinus alleviate intestinal ischemia/reperfusion injury through promoting the release of interleukin-10 from M2 macrophages via Toll-like receptor 2 signaling.Microbiome. 2022 Mar 3;10(1):38. doi: 10.1186/s40168-022-01227-w. Microbiome. 2022. PMID: 35241180 Free PMC article.
-
Immunoregulatory potential of exopolysaccharide from Lactobacillus rhamnosus KL37: effects on the production of inflammatory mediators by mouse macrophages.Int J Exp Pathol. 2011 Dec;92(6):382-91. doi: 10.1111/j.1365-2613.2011.00788.x. Epub 2011 Sep 22. Int J Exp Pathol. 2011. PMID: 21950581 Free PMC article.
-
Evaluation of probiotic potential of yeasts isolated from traditional cheeses manufactured in Serbia and Croatia.J Intercult Ethnopharmacol. 2015 Jan-Mar;4(1):12-8. doi: 10.5455/jice.20141128051842. Epub 2015 Jan 3. J Intercult Ethnopharmacol. 2015. PMID: 26401378 Free PMC article.
-
Study on the Antipyretic and Anti-inflammatory Mechanism of Shuanghuanglian Oral Liquid Based on Gut Microbiota-Host Metabolism.Front Pharmacol. 2022 Jun 28;13:843877. doi: 10.3389/fphar.2022.843877. eCollection 2022. Front Pharmacol. 2022. PMID: 35837285 Free PMC article.
-
Mapping the relationships between inflammatory bowel disease and comorbid diagnoses to identify disease associations.Eur J Gastroenterol Hepatol. 2020 Oct;32(10):1341-1347. doi: 10.1097/MEG.0000000000001869. Eur J Gastroenterol Hepatol. 2020. PMID: 32804850 Free PMC article.
References
-
- Albrecht D, Jungi TW. Luminol-enhanced chemiluminescence induced peripheral blood-derived human phagocytes: obligatory requirement of myeloperoxidase endocytosis by monocytes. J. Leukoc. Biol. 1993;54:300–306. - PubMed
-
- Baumgart DC, Dignass AU. Intestinal barrier function. Curr. Opin. Clin. Nutr. Metab. Care. 2002;5:685–694. - PubMed
-
- Becker C, Dornhoff H, Neufert C, et al. Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis. J. Immunol. 2006;177:2760–2764. - PubMed
-
- Bibiloni R, Fedorak RN, Tannock GW, et al. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 2005;100:1539–1546. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous